Abstract:Key PointsThe versatile nucleotide excision repair (NER) pathway removes helix-distorting DNA damage in a multistep 'cut and patch'-type reaction. Two damage detection subpathways exist: global genomic NER (GG-NER) removes DNA damage anywhere in the genome, and transcription-coupled NER (TC-NER) specifically repairs transcription-blocking lesions in actively transcribed DNA.GG-NER and TC-NER have a remarkable ability to remove a wide variety of structurally unrelated DNA lesions owing to their indirect manner of DNA-damage detection. GG-NER is initiated by the recognition of damage-induced DNA helix distortions, and TC-NER is initiated by stalling of RNA polymerase II (RNA Pol II) at a lesion.Following lesion recognition, the presence of DNA damage is verified, structure-specific endonucleases are recruited to incise the damaged strand on both sides of the lesion and thereby excise the damage along with short flanking sequences. The excised strand is repaired by gap-filling DNA synthesis using the intact complementary strand as a template.The activity of NER proteins is tightly regulated by post-translational modifications. In particular, the DNA-damage recognition steps are extensively regulated by complex ubiquitylation events.Extensive chromatin remodelling facilitates the DNA-damage detection steps of GG-NER and TC-NER, which results in restarting of transcription after repair and restoration of the original chromatin configuration.Processing of lesions during NER results in repair intermediates that can activate the DNA-damage signalling cascade mediated by ATR, which induces phosphorylation and ubiquitylation of histones H2A and H2A.X.NER deficiency is exemplary of the severe consequences of DNA damage. Congenital defects in NER genes cause various human syndromes, which exhibit a wide range of clinical symptoms, including extreme (skin) cancer predisposition, severe neurodevelopmental defects and premature ageing. This clinical heterogeneity can be explained by the diverse lesions repaired by NER, the existence of two NER subpathways and the multifunctionality of several NER proteins. Differences in the fate of lesion-stalled RNA Pol II may explain the extreme heterogeneity of transcription-coupled repair disorders.

Connecting Dots between Nucleotide Biosynthesis and DNA Lesion Repair/Bypass in Cancer

DNA Damage, Repair, and Cancer Metabolism

Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy

The Importance of DNA Repair in Tumor Suppression

Understanding nucleotide excision repair and its roles in cancer and ageing

DNA Damage/Repair Management in Cancers

Strand-resolved mutagenicity of DNA damage and repair

DNA Base Excision Repair Intermediates Influence Duplex-Quadruplex Equilibrium

A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance

Transcription-Coupled Nucleotide Excision Repair and the Transcriptional Response to UV-Induced DNA Damage

Post-replicative lesion processing limits DNA damage-induced mutagenesis

Understanding the interplay between dNTP metabolism and genome stability in cancer

Unprocessed Genomic Uracil as a Source of DNA Replication Stress in Cancer Cells

Evolving Insights: How DNA Repair Pathways Impact Cancer Evolution

DNA single-strand break repair and human genetic disease

Transcription-coupled nucleotide excision repair: New insights revealed by genomic approaches

"Bridging the DNA divide": Understanding the interplay between replication- gaps and homologous recombination proteins RAD51 and BRCA1/2

DNA Damage and Its Role in Cancer Therapeutics

Incorporation of a nucleoside analog maps genome repair sites in postmitotic human neurons

Recent advances in DNA damage repair mechanism